Choroidal thickness in convalescent Vogt-Koyanagi-Harada disease

Retina

Volumn 34, Issue 4, 2014, Pages 775-780

  Takahashi, Hiroyuki ^a   Takase, Hiroshi ^a   Ishizuka, Atsuko ^a   Miyanaga, Masaru ^a   Kawaguchi, Tatsushi ^a   Ohno Matsui, Kyoko ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE DURATION; EYE DISEASE; EYE INFLAMMATION; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; PERIPAPILLARY ATROPHY; SUBFOVEAL CHOROIDAL THICKNESS; SUNSET GLOW FUNDUS; VISUAL SYSTEM PARAMETERS; VOGT KOYANAGI SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CHOROID; CONVALESCENCE; FEMALE; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MIDDLE AGED; OPTIC ATROPHY; PULSE THERAPY, DRUG; TOMOGRAPHY, OPTICAL COHERENCE; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY;

EID: 84897576948     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182a6b3f6     Document Type: Article

References (21)

1. Ohguro N, Sonoda KH, Takeuchi M, et al. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol 2012;56:432-435.
2. Yamaki K, Gocho K, Hayakawa K, et al. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000;165:7323-7329.
3. Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006;47:2547-2554.
4. Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007;27:81-85.
5. Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res 1990;9:35-0.
6. Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 1990;108:1421-1426.
7. Herbort CP. Fluorescein and indocyanine green angiography for uveitis. Middle East Afr J Ophthalmol 2009;16:168-187.
8. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007;27: 173-182.
9. Miyanaga M, Kawaguchi T, Miyata K, et al. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 2010;54:377-382.
10. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.
11. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011; 31:502-509.
12. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 2011;31:510-517.
13. Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina 2012;32:2061-2069.
14. Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2012;250:1089-1095.
15. da Silva FT, Sakata VM, Nakashima A, et al. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol 2013;97: 70-74.
16. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131:647-652.
17. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.
18. Neri P, Manoni M, Fortuna C, et al. Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants. Int Ophthalmol 2010;30: 583-590.
19. Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, et al. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol 2012;90: 603-608.
20. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606.
21. Jap A, Luu CD, Yeo I, Chee SP. Correlation between peripa-pillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease. Eye (Lond) 2008;22:240-245.